Patent · US Active

Diaminopyrimidines as P2X3 and P2X2/3 modulators

US7589090B2 · kind B2 · utility

1Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 2008
Grant dateSep 15, 2009
Priority date
Expiry dateMar 13, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds and methods for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist, the compounds being of formula (I):wherein R1, R2, R3 and R4 are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.